Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

HemostOD SA

History from 24 Jun 2020

UID
CHE-278.248.627
Legal form
AG
Canton
VD
Founded
24 Jun 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 243k
61k121k182k243k25 May 2021 · CHF 141k28 Jun 2024 · CHF 165k21 Aug 2025 · CHF 211k30 Oct 2025 · CHF 230k16 Jul 2026 · CHF 243kRound announced 3 Oct 2025202120222023202420252026
  • shares
  • round announced

Record

  1. Company formed

    Founded 24 Jun 2020

    SHAB HR01-1004934540 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 140’872.73
    Shares
    100 → 14’087’273
    New shares, % of post-step shares
    — (nominal value per share changed)

    Les 100 actions nominatives de CHF 1'000 sont transformées en 10'000'000 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. Le capital-actions de CHF 100'000 a été libéré ultérieurement à concurrence de CHF 50'000. Augmentation ordinaire du capital-actions. Nouveau capital-actions entièrement libéré: CHF 140'872.73, divisé en 14'087'273 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005191404 ↗
  3. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    140’872.73 → 164’822.16
    Shares
    14’099’393 → 16’482’216
    New shares, % of post-step shares
    14.5% (2’382’823 new)

    Nouveau capital-actions entièrement libéré: CHF 140'993.93, divisé en 14'099'393 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. Nouveau capital-actions entièrement libéré: CHF 164'822.16, divisé en 16'482'216 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006070529 ↗
  4. Capital increase

    Likely financing

    Paid in cash and by other means

    Nominal capital
    164’822.16 → 211’494.61
    Shares
    16’482’216 → 21’149’461
    New shares, % of post-step shares
    22.1% (4’667’245 new)

    Nouveau capital-actions entièrement libéré: CHF 211'494.61, divisé en 21'149'461 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. L'assemblée générale a introduit une clause statutaire relative à une marge de fluctuation du capital-actions par décision du 29.07.2025; pour les détails, voir les statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006413893 ↗
  5. Capital band adopted

    SHAB HR02-1006413893 ↗
  6. Round announced

    possible match · low match confidence

    Announcement ↗
  7. Capital increase

    Likely financing · possible confirmation

    Paid in cash

    Nominal capital
    211’494.61 → 229’539.84
    Shares
    21’149’461 → 22’953’984
    New shares, % of post-step shares
    7.9% (1’804’523 new)

    Augmentation ordinaire du capital-actions dans la limite de la marge de fluctuation du capital. Nouveau capital-actions entièrement libéré: CHF 229'539.84, divisé en 22'953'984 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. Le conseil d'administration a modifié la clause statutaire relative à une marge de fluctuation du capital-actions par décision du 13.10.2025; pour les détails, voir les statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006471607 ↗
  8. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    229’539.84 → 242’843.29
    Shares
    22’953’984 → 24’284’329
    New shares, % of post-step shares
    5.5% (1’330’345 new)

    Augmentation ordinaire du capital-actions dans la limite de la marge de fluctuation du capital. Nouveau capital-actions entièrement libéré: CHF 242'843.29, divisé en 24'284'329 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts. Le conseil d'administration a modifié la clause statutaire relative à une marge de fluctuation du capital-actions par décision du 30.06.2026; pour les détails, voir les statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.66 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006709008 ↗

Published by 8 Oct 2026